[1] 曾磊.恶性肿瘤风险指数与肿瘤标志物用于盆腔包块良恶性诊断的临床价值[J].东南大学学报(医学版),2016,35(6):965-969.
[2] 金蔚,党胜春.卵巢癌中TBL1XR1基因的拷贝数扩增及其临床意义[J].东南大学学报(医学版),2018,37(6):1072-1074.
[3] SHARMA M,KHANGAR B,MALLYA V,et al.Coexisting Brenner tumor and endometrial carcinoma[J].J Midlife Health,2017,8(2):89-91.
[4] ZIADI S,TRIMECHE M,HAMMEDI F,et al.Bilateral proliferating Brenner tumor of the ovary associated with recurrent urothelial carcinoma of the urinary bladder[J].N Am J Med Sci,2010,2(1):39-41.
[5] HAN J H,KIM D Y,LEE S W,et al.Intensive systemic chemotherapy is effective against recurrent malignant Brenner tumor of the ovary:An analysis of 10 cases within a single center[J].Taiwan J Obstet Gynecol,2015,54(2):178-182.
[6] GEZGINÇ K,KARATAYLI R,YAZICI F,et al.Malignant Brenner tumor of the ovary:analysis of 13 cases[J].Int J Clin Oncol,2012,17(4):324-329.
[7] NASIOUDIS D,SISTI G,HOLCOMB K,et al.Malignant Brenner tumors of the ovary:a population-based analysis[J].Gynecol Oncol,2016,142(1):44-49.
[8] KING L,GOGOI R P,HUMMEL C,et al.Malignant Brenner tumor:Two case reports[J].Case Rep Womens Health, 2018,20:e00082.
[9] 王建华,韦强,李惠,等.卵巢Brenner瘤的MSCT表现与病理对照分析[J].临床放射学杂志,2016,35(4):560-564.
[10] 毕玉晰,李洋洋,蒋杰,等.卵巢恶性Brenner瘤一例报告并文献复习[J].国际妇产科学杂志,2018,45(4):473-476.
[11] 宋芳,沈铭红,陈汝蕾,等.卵巢Brenner肿瘤14例临床病理分析[J].临床与实验病理学杂志,2019(1):105-107.
[12] KONDI-PAFITI A,KAIRI-VASSILATOU E,IAVAZZO C,et al.Clinicopathological features and immunoprofile of 30 cases of Brenner ovarian tumors[J].Arch Gynecol Obstet,2012,285(6):1699-1702.
[13] CUATRECASAS M,CATASUS L,PALACIOS J,et al.Transitional cell tumors of the ovary:a comparative clinicopathologic,immunohistochemical,and molecular genetic analysis of Brenner tumors and transitional cell carcinomas[J].Am J Surg Pathol,2009,33(4):556-567.
[14] XIAO S,ZHOU Y,YI W,et al.Fra1 is downregulated in cervical cancer tissues and promotes cervical cancer cell apoptosis by p53 signaling pathway in vitro[J].Int JOncol,2015,46(4):1677-1684. |